A 3-year course of bulevirtide monotherapy may cure HDV infection in patients with cirrhosis-Reference-Cited by-同舟云学术

A 3-year course of bulevirtide monotherapy may cure HDV infection in patients with cirrhosis

Published:2023-04 Issue:4 Volume:78 Page:876-880
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Anolli Maria Paola^ORCID,Degasperi Elisabetta,Allweiss Lena,Sangiovanni Angelo^ORCID,Maggioni Marco,Scholtes Caroline^ORCID,Oberhardt Valerie,Neumann-Haefelin Christoph^ORCID,Dandri Maura,Zoulim Fabien^ORCID,Lampertico Pietro^ORCID

Funder

Agence Nationale de la Recherche

Gilead Sciences

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Hepatology

Reference11 articles.

1. 2019 EASL-AASLD HBV treatment endpoints conference faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - report from the 2019 EASL-AASLD HBV treatment endpoints conference;Cornberg;J Hepatol,2020

2. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease;Urban;Gut,2021

3. Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of myrcludex B in combination with tenofovir in patients with chronic HBV/HDV co-infection;Wedemeyer;J Hepatol,2018

4. Efficacy and safety of bulevirtide monotherapy given at 2 mg or 10 mg dose level once daily for treatment of chronic hepatitis delta: week 48 primary end point results from a phase 3 randomized, multicenter, parallel design study;Wedemeyer;J Hepatol,2022

5. Real life study of bulevirtide in chronic hepatitis delta: preliminary results of the ANRS HD EP01 BuleDelta prospective cohort;Fontaine;J Hepatol,2022

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronische Hepatitis-B- und Hepatitis-D-Virusinfektion;DMW - Deutsche Medizinische Wochenschrift;2024-08

2. Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D;New England Journal of Medicine;2024-07-11

3. Reply to: “Increase in HDV replication during steroid therapy – potential implications for testing and treatment strategies”;Journal of Hepatology;2024-07

4. Advances in hepatitis delta research: emerging insights and future directions;Sexually Transmitted Infections;2024-06-24

5. Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies;Journal of Hepatology;2024-06